Liver Transplantation Restores Low Serum Levels of Very Low Density and High Density Lipoproteins in End-stage Primary Biliary Cirrhosis

References

• Sabesin S M, Weidman S W. Lipoprotein abnormalities in primary biliary cirrhosis: information concerning control of plasma high density lipoprotein levels. Gastroenterology 1985; 89: 1426–9
   PubMed Web of Science ®Google Scholar
• Baruch Y, Brook J G, Eidelman S, Aviram M. Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis. Atherosclerosis 1984; 53: 151–62
   Google Scholar
• Jahn C E, Schaefer E J, Taam L A, et al. Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well altered cholesterol esterification. Gastroenterology 1985; 89: 1266–78
   PubMedGoogle Scholar
• Teramoto T, Kato H, Hashimoto Y, Kinoshita M, Toda G, Oka H. Abnormal high density lipoprotein of primary biliary cirrhosis analyzed by high performance liquid chromatography. Clin Chim Acta 1985; 149: 135–48
   Google Scholar
• Aly A, Carlson K, Johansson C, Kirstein P, Rössner S, Wallentin L. Lipoprotein abnormalities in patients with early primary biliary cirrhosis. EurJ Clin Invest 1984; 14: 155–62
   PubMed Web of Science ®Google Scholar
• Eisenberger S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017–58
   Google Scholar
• Palombo J D, Lopes S M, Zeisel S H, et al. Effectiviness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Gastroenterology 1987; 93: 1170–7
   Google Scholar
• Koopman B J, van der Molen J C, Wolthers B G, de Jager A EJ, Waterhau R J, Gibs C H. Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack in diagnosing CTX (cerebrotendinous xanthomatosis). Clin Chim Acta 1984; 137: 305–15
   PubMed Web of Science ®Google Scholar
• Nikkilä K, Miettinen T A. Serum cholesterol precursors, cholestanol and plant sterols in primary biliary cirrhosis. Scand J Gastroenterol 1988; 23: 967–72
   PubMed Web of Science ®Google Scholar
• Nikkilä K, Höckerstedt K, Miettinen T A. High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation. Hepatology 1991; 13: 663–9
   Google Scholar
• Scheuer P J. Liver biopsy interpretation, 3rd ed. Williams and Wilkins, Baltimore 1980; 47–59
   Google Scholar
• Sherlock S, Scheuer P J. The presentation and diagnosis of 100 patients with primary cirrhosis. N Engl J Med 1974; 289: 671–8
   Google Scholar
• Höckerstedt K, Lautenschlager I, Ahonen J, et al. Diagnosis of acute rejection in liver transplantation. J Hepatol 1988; 6: 217–21
   Google Scholar
• Finley P R, Schifman R B, Williams R J, Lichti D A. Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymatic measurement. Clin Chem 1978; 24: 931–3
   PubMed Web of Science ®Google Scholar
• Diagnostica. May, 1983, Monotest Cholesterol, CHOD-PAP method, Boehringer Mannheim GmbH
   Google Scholar
• Triglyceride GPO-PAP. Boehringer Mannheim automated analysis for Hitachi 705, Boehringer Mannheim GmbH. Diagnostica. May, 1983
   Google Scholar
• Kuusi T, Palosuo T, Ehnholm C. Immunonephelometric measurement of human plasma apoproteins A1 and A2: An assay performed by consecutive addition of antisera to a single specimen. Scand J Clin Lab Invest 1985; 45: 245–53
   PubMed Web of Science ®Google Scholar
• Miettinen T A. Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column. Clin Chim Acta 1982; 124: 245–8
   PubMed Web of Science ®Google Scholar
• Miettinen T A, Koivisto P. Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass. Bile acids and cholesterol in health and disease., G Paumgartner, A Stiehl, W Gerok. MTP Press, Lancaster 1983; 183–7
   Google Scholar
• BMDP. Statistical software. University of California Press, Los Angeles 1987
   Google Scholar
• Nikkilä E A. HDL in relation to the metabolism of triglyceride-rich lipoproteins. Clinical and metabolic aspects of high-density lipoproteins., N E Miller, G J Miller. Elsevier Science Publishers, Amsterdam 1984; 217–45
   Google Scholar
• Miller N E. High density lipoprotein: A major risk factor for coronary atherosclerosis. Bailliere's Clinical endocrinology and metabolism. 1987; 1: 603–22, No 3
   PubMed Web of Science ®Google Scholar
• Taskinen M R, Kuusi T. Enzymes involved in triglyceride hydrolysis. Bailliere's Clinical Endocrinology and Metabolism. 1987; 1: 639–66, No. 3
   PubMed Web of Science ®Google Scholar
• Nikkilä E A, Kuusi T, Taskinen M R. Role of lipoprotein lipase and hepatic endothelial lipase in the metabolism of high density lipoprotein: A novel concept on cholesterol transport in HDL cycle. Metabolic risk factors in ischemic cardiovascular disease., L A Carlson, B Pernow. Raven Press, New York 1982; 205–15
   Google Scholar
• Patsch J R, Gotto A M, Jr., Olivercrona T, Eisenberg S. Formation of high density lipoprotein2-like particles in lipolysis of very low density lipoproteins in vitro. Proc NatlAcadSci USA 1978; 75: 4519–23
   PubMed Web of Science ®Google Scholar
• Nikkilä E A, Kuusi T, Harno M, Tikkanen M J, Taskinen M R. Lipoprotein lipase and hepatic endothelial lipase are key enzymes in the regulation of plasma HDL, particularly HDL. Atherosclerosis V., A M Gotto, Jr., L C Smith, B Allen. Springer Verlag, New York 1980; 387–92
   Google Scholar
• Kuusi T, Ehnholm C, Viikari J, et al. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo-and hyperalphalipoproteinemia. J Lipid Res 1989; 30: 1117–26
   Google Scholar
• Nikkilä E A, Kuusi T, Taskinen M R, Tikkanen M J. Regulation of lipoprotein metabolism by endothelial lipolytic enzymes. Treatment of hyperlipoproteinemia., L A Carlson, A G Olsson. Raven Press, New York 1984; 77–84
   Google Scholar
• Sauar J, Skrede S, Blomhoff J P. Hepatic lipase and lipoprotein lipase in postheparin plasma in liver disease. Relations to plasma proteins. Clin Chim Acta 1978; 84: 213–23
   PubMed Web of Science ®Google Scholar
• Koizumi J, Mabuchi H, Yoshimura A, et al. Deficiency of serum cholesterylester transfer activity in patients with familial hyperalphalipoproteinemia. Arteriosclerosis 1985; 58: 175–86
   Google Scholar
• Kurasawa T, Yokoyama S, Miyake Y, Yamamura T, Yamamoto A. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia. J Biochem 1985; 98: 1499–508
   Google Scholar
• Floren C H, Gustafson A. Apolipoproteins A—I, A—II and E in cholestatic liver disease. Scand J Clin Lab Invest 1985; 45: 103–8
   PubMed Web of Science ®Google Scholar
• Savdie E, Gibson J C, Stewart J H, Simons L A. High-density lipoprotein in chronic renal failure and after renal transplantation. Br Med J 1979; I: 928–30
   Google Scholar
• Jung K, Scheifler A, Blank W, Scholz D, Schulze B-D, Hansen C. Changed composition of high-density lipoprotein subclasses HDL2 and HDL, after renal transplantation. Transplantation 1988; 46: 407–9
   PubMedGoogle Scholar
• Zimmerman J, Fainaru M, Eisenberg S. The effects of prednisone therapy on plasma lipoproteins and apoproteins: a prospective study. Metabolism 1984; 33: 521–6
   Google Scholar
• Taskinen M R, Kuusi T, Yki-Järvinen H, Nikkilä E A. Short-term effects of prednisone on serum lipids and high density lipoprotein subtractions in normolipidemic healthy men. J Clin Endocrinol Metab 1988; 67: 291–9
   Google Scholar
• Ettinger W H, Jr., Hazzard W R. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 1988; 37: 1055–8
   Google Scholar
• Ballantyne C M, Podet E J, Patsch W P, et al. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA 1989; 262: 53–6
   PubMed Web of Science ®Google Scholar
• Valthsala A, Weinberg R B, Schoenberg, et al. Lipid abnormalities in renal transplant recipients treated with cyclosporine. Transplant Proc 1989; 21: 3670–3
   Google Scholar
• Taskinen M R, Tulikoura I, Nikkilä E, Ehnholm C. Effect of parenteral hyperalimentation on serum lipoproteins and on lipoprotein lipase activity of adipose tissue and skeletal muscle. Eur J Clin Invest 1981; 11: 317–23
   Google Scholar
• Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E, Taskinen M R. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 37: 859–65
   PubMed Web of Science ®Google Scholar
• Ulevitsch R J, Johnston A R, Weinstein D B. New function for high density lipoproteins. Their participation in intravascular reaction of bacterial lipopolysaccharides. J Clin Invest 1979; 64: 1516–24
   Google Scholar
• Nikkilä E A, Kuusi T, Myllynen P. High density lipoprotein and apolipoprotein A—I during physical inactivity. Atherosclerosis 1980; 37: 457–62
   Google Scholar
• Björkhem I, Skrede S. Familial diseases with storage of sterols other than cholesterol: Cerebrotendinous xanthomatosis and phytosterolemia. The metabolic basis of inherited disease, C R Scriver, A L Beaudet, W S Sly, D Valle, J B Stanbury, J B Wyngaarden, D S Fredrickson. McGraw-Hill Information Services co, New York 1989; 1283–302, 6th ed
   Google Scholar
• Miettinen T A, Tilvis R S, Kesäniemi Y A. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 1989; 38: 136–40
   Web of Science ®Google Scholar